These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2903993)

  • 1. Bismuth absorption from the colloidal subcitrate.
    Hespe W; Staal HJ; Hall DW
    Lancet; 1988 Nov; 2(8622):1258. PubMed ID: 2903993
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.
    Muñoz DJ; Tasman-Jones C; Pybus J
    Gut; 1992 May; 33(5):592-6. PubMed ID: 1377152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of pharmacokinetic studies with De-Noltab.
    Aliment Pharmacol Ther; 1989 Aug; 3(4):409-13. PubMed ID: 2518856
    [No Abstract]   [Full Text] [Related]  

  • 5. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
    Dresow B; Fischer R; Gabbe EE; Wendel J; Heinrich HC
    Scand J Gastroenterol; 1992 Apr; 27(4):333-6. PubMed ID: 1589712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of bismuth-containing compounds.
    Lambert JR
    Rev Infect Dis; 1991; 13 Suppl 8():S691-5. PubMed ID: 1925310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of bismuth in rabbit blood serum and tissues after administration of pharmaceuticals containing Bi2O3.
    Zommer-Urbańska S; Bulska E; Pawlaczyk R; Kukliński M
    Acta Pol Pharm; 1994; 51(1):7-10. PubMed ID: 7976437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacokinetics: colloidal bismuth subcitrate.
    Benet LZ
    Scand J Gastroenterol Suppl; 1991; 185():29-35. PubMed ID: 1957122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
    Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease.
    Bianchi Porro G; Lazzaroni M; Cortvriendt WR
    Digestion; 1987; 37 Suppl 2():47-52. PubMed ID: 3305118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
    Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J
    Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate.
    Stiel D; Murray DJ; Peters TJ
    Gut; 1985 Apr; 26(4):364-8. PubMed ID: 3979909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
    Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Pounder RE
    Gastroenterology; 1991 Oct; 101(4):889-94. PubMed ID: 1889712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
    Madaus S; Schulte-Frohlinde E; Scherer C; Kämmereit A; Schusdziarra V; Classen M
    Aliment Pharmacol Ther; 1992 Apr; 6(2):241-9. PubMed ID: 1288519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate.
    Işlek I; Uysal S; Gök F; Dündaröz R; Küçüködük S
    Pediatr Nephrol; 2001 Jun; 16(6):510-4. PubMed ID: 11420918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
    Balint GA
    Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
    Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
    Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and cerebrospinal fluid accumulation of aluminium and bismuth in volunteers taking short course anti-ulcer therapy.
    Gane E; Sutton MM; Pybus J; Hamilton I
    J Gastroenterol Hepatol; 1996 Oct; 11(10):911-5. PubMed ID: 8912126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
    Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
    J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.